1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA KDF1 CTRPv2 pan-cancer AAC 0.14 0.0006
mRNA SH2D4A CTRPv2 pan-cancer AAC -0.12 0.0006
mRNA IL13RA2 CTRPv2 pan-cancer AAC -0.11 0.0006
mRNA KMT2C CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA CYP4X1 CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA NRG2 CTRPv2 pan-cancer AAC -0.11 0.0006
mRNA MPPED1 CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA RP11-12J10.3 CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA SSPO CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA UBXN7 CTRPv2 pan-cancer AAC 0.11 0.0006
Download CSV